Preparation and in-vitro evaluation of indomethacin nanoparticles

DARU, Journal of Pharmaceutical Sciences

Volumn 18, Issue 3, 2010, Pages 185-192

  Rezaei Mokarram, A ^a   Kebriaee zadeh, A ^b   Keshavarz, M ^c   Ahmadi, A ^c   Mohtat, B ^c  

^a RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Controlled precipitation; Indomethacin; Nano solid suspension; Polyvinyl pyrrolidone

Indexed keywords

INDOMETACIN; NANOPARTICLE; POVIDONE;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEASIBILITY STUDY; HYDROGEN BOND; IN VITRO STUDY; INFRARED SPECTROSCOPY; NANOTECHNOLOGY; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; VISCOELASTICITY; X RAY DIFFRACTION;

EID: 78149445307     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Lipinski C. Poor aqueous solubility-an industry wide problem in drug discovery. Am. Pharm. Rev. 2002; 5: 82-85.
2. Müller R.H, Mschwitzer J, Bushrab F.N. Manufacturing of nanoparticles by milling and homogenization techniques. In: Gupta RB, Kompella UB. eds. Nanoparticle Technology for Drug Delivery, Drugs and the Pharmaceutical Sciences. vol. 159. Taylor & Francis Group, LLC, New York, 2006; pp. 21-51.
3. Kesisoglou F, Panmai S, Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliver Rev. 2007; 59: 631-644.
4. Eerikainen H, Watanabe W, Kauppinen E.I, Ahonen P.P. Aerosol flow reactor method for synthesis of drug nanoparticles. Eur J Pharm Biopharm. 2003; 55: 357-360.
5. Trotta M, Gallarate M, Carlotti M.E, Morel S. Preparation of griseofulvin nanoparticles from water- dilutable microemulsions. Int J Pharm. 2003; 254: 235-242.
6. Thakur R, Gupta R.B. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvents (RESS-SC) process. Int J Pharm. 2006; 308: 190-199.
7. Chen J, Zhou M, Shao L, Wang Y, Yun J, Chew N.Y.K, Chan H. Feasability of preparing nanodrugs by high-gravity reactive precipitation. Int J Pharm. 2004; 269: 267-274.
8. Rogers T.L, Gillespie I.B, Hitt J.E, Fransen K.L, Crowl C.A, Tucker C.J, Kupperblatt G.B, Becker J.N, Wilson D.L, Todd C, Broomall C.F, Evans J.C, Elder E.J. Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs. Pharm Res. 2004; 21: 2048-2057.
9. Kockbek P, Baumgartner S, Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm. 2006; 312: 179-186.
10. Möschwitzer J, Achleitner G, Pomper H, Muller R.H. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur J Pharm Biopharm. 2004; 58: 615-619.
11. Rabinow B.E. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004; 3: 785-796.
12. Newa M, Bhandari K.H, Li D.X, Kwon T, Kim J.A, Yoo B.K, Woo J.S, Lyoo W.S, Yong C.S, Choi H.G. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm. 2007; 343: 228-237.
13. Shibata Y, Fujii M, Sugamura Y, Yoshikawa R, Fujimoto S, Nakanishi S, Motosugi Y, Koizumi N, Yamada M, Ouchi K, Watanabe Y. The preparation of a solid dispersion powder of indomethacin with crospovidone using a twin-screw extruder or kneader. Int J Pharm. 2009; 365: 53-60.
14. Khalili N, Rezaei Mokarram A. Evaluation of dissolution rate and physical stability of indomethacin-PVP co-precipitate. Pajouhandeh. 2002; 2, 129-139.
15. Kaneniwa N, Otsuka M, Hayashi T. Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol. Chem Pharm Bull. 1985; 33: 3447-3455.
16. Yoshioka M, Hancock B.C, Zografi G. Crystallization of amorphous indomethacin above and below its glass transition temperature. J Pharm Sci. 1994; 84: 1700-1705.
17. Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharma Res. 1997; 14, 1691-7698.
18. Yoshioka M, Hancock B.C, Zografi G. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipiatates. J Pharm Sci. 1995; 84: 983-986.
19. Takayama K, Nambu N, Nagai T. Dissolution kinetics of copercipitates of indomethacin with poly- vinylpyrrolidone. Chem Pharm Bull. 1980; 28: 3304-3309.
20. Liversidge G.G, Phillips C.P, Cundy K.C. Method to reduce particle size growth during lyophilization. US Patent US5302401 1994.
21. Konan Y.N, Gurny R, Allémann E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm. 2002; 233: 239-252.
22. Pongperapat A. Nanoparticle formation of poorly water-soluble drug by co-grinding with polymer and stabilizing agent, a thesis for Dep. of pharm. tech. school of medical and pharmaceutical sciences, Chiba univer. Japan, 2006.
23. Fini A, Cavallari C, Ospitali F. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles. Eur J Pharm Biopharm. 2008; 70: 409-420.
24. Passerini N, Albertini B, Gonzalez-Rodriguez M.L, Cavallari C, Rodrigez L. Preparation and characterization of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur J Pharm Sci. 2002; 15: 71-78.
25. O'Brien M, McCauley J, McCauley J, Cohen E. Indomethacin, In: Analytical Profile of Drug Substances. Vol. 13, Ed. Florey, K., ACADEMIC PRESS, INC. Orlando, Florida 52887, 1984; Pp. 212-235.
26. Chen Y, Zhang G.G.Z, Neilly J, Marsh K, Mawhinney D, Sanzgiri Y.D. Enhancing the bioavailability of ABT-963 using solid dispersion containing pluronic F-68. Int J Pharm. 2004; 286: 69-80.
27. Passerini N, Albertini B, Perissutti B, Rodriguez L. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel. Int J Pharm. 2006; 318: 92-102.
28. Seo A, Holm P, Kristensen H.G, Schæfer T. The preparation of agglomerates containing solid dispersions of diazepam by melt agglomeration in a high shear mixer. Int J Pharm. 2003; 259: 161-171.
29. Yu H, Chun M.K, Choi H.K. Preparation and characterization of piroxicam/poloxamer solid dispersion prepared by melting method and solvent method. J Kor Pharm Sci. 2007; 37: 1-5.
30. Grant D.J.W, Brittain H.G. Solubility of pharmaceutical solids, In: Brittain HG, ed. Physical Characterization of Pharmaceutical Solids, Marcel Dekker Inc. New York, 1995; Pp. 322-381.
31. Muller R.H, Bohm B.H.L, Grau M.J. Nanosuspensions: a formulation approach for poorly soluble and poorly bioavailable drugs. In: Wise DL. ed. Handbook of Pharmaceutical Controlled Release Technology, first ed. Marcel Dekker, New York, 2000; pp. 345-357.
32. Lindenberg M, Knopp S, Dressman J.B. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004; 58: 265-278.